Data protection Impressum

Personalized Medicine

Novostia has raised CHF 5.6 million in a new financing round and appointed Soad El Ghazouani as CEO to accelerate the development of its TRIFLO heart valve technology.

Novostia secures CHF 5.6 million to accelerate the development of its heart valve

24 September 2024

ONWARD Medical has secured a USD 1.1 million grant from the Christopher & Dana Reeve Foundation to further develop its ARC-BCI system, which aims to restore thought-controlled movement to people with spinal cord injuries.

ONWARD Medical awarded USD 1.1 million by the Christopher & Dana Reeve Foundation

17 September 2024

Biotech Vandria has raised an additional CHF 14 million to accelerate the development of innovative treatments for age-related and chronic diseases, bringing its total Series A financing to CHF 28.3 million.

Vandria secures over CHF 14 million to advance age-related disease therapies

3 September 2024

AC Immune’s ACI-35.030 (now called JNJ-2056), an active-immunotherapy candidate targeting the pathologic form of the Tau protein, has received Fast Track designation from the U.S. Food and Drug Administration (FDA).

AC Immune receives FDA Fast Track designation for Alzheimer’s disease therapy

6 August 2024

Geneva-based Agora Care has closed a financing round of CHF 2.2 million to support its expansion into the US market and increase patient enrollment in Switzerland and Europe.

Medical imaging specialist Agora Care secures CHF 2.2 million for US market expansion

5 August 2024

Biopôle-based start-up Vanarix has secured CHF 4 million to initiate new clinical trials and automate the manufacturing of its Cartibeads.

Vanarix raises CHF 4 million to advance cartilage regeneration

15 July 2024

The FONGIT Innovation Fund has awarded funding to three cutting-edge tech projects: CHF 100,000 seed loans for returning winners Planeto and HekeTiss, and a CHF 50,000 grant for newcomer LightEye.

CERN and UNIGE spin-offs awarded FIF Funding

2 July 2024

BioAlps, the life sciences cluster of Western Switzerland, offers a dynamic network, an innovative and supportive environment and direct access to the region's vibrant life sciences ecosystem.

BioAlps, Western Switzerland’s life sciences cluster

iOnctura has secured EUR 80 million in a Series B funding round to advance innovative cancer therapies, with a focus on neglected cancers such as uveal melanoma.

iOnctura secures EUR 80 million Series B financing to advance cancer treatments

25 June 2024

Thego.care has launched an online store for innovative medical armbands to enhance patient comfort and care.

Thego.care launches an online store for its innovative medical armbands

24 June 2024

1 2 3 4 5 6 7 8 … 18